Work

Abstract 956: HB-200: A novel viral vector vaccine platform that can improve immunotherapy treatment in HPV16+ HNSCC

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-956

Authors: Sydney Fisher, Matthew Ji, Yuxuan Miao

Institution: University of Chicago

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409691279

Cites:

Cited by:

Related to: 10